Literature DB >> 34916679

[Clinical characteristics of central nervous system involvement in IgG4 related diseases].

G Y Meng1,2, Y X Zhang1, Y X Zhang1, Y Y Liu1,4.   

Abstract

OBJECTIVE: To improve the understanding of the clinical characteristics of immunoglobulin G4-related disease (IgG4-RD) with central nervous system (CNS) involvement, so as to contribute to the early diagnosis and treatment.
METHODS: In this study, 10 patients with IgG4-RD with CNS involvement were selected. Clinical data including demographic features, clinical manifestations, organ involvement, laboratory findings, radiological results, pathology, treatments and outcomes were collected retrospectively.
RESULTS: Among the 10 IgG4-RD patients complicated with CNS involvement, 6 cases manifested as pituitary involvement and 4 cases manifested as dural involvement. Only 2 patients had nervous system involvement alone, while the left patients were complicated with other organ involvement besides nervous system. Half of the patients presented nervous system involvement as the initial manifestation, and the main symptoms of nervous system included polydipsia, polyuria, headache, decreased vision and so on. In the laboratory examination, the serum IgG4 level was increased in 9 cases (90.0%), and the total serum IgE was increased in 7 cases (87.5%). At the same time, their IgG, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were increased, while complement (C) 3 and C4 were decreased in some patients. Eight patients underwent tissue biopsies in different parts, the pathological examination showed a large number of lymphocyte and plasma cell infiltration, accompanied by fibrous tissue proliferation in part. All the patients were treated with glucocorticoids, and 8 cases (80%) were given immunosuppressants at the same time, and 3 cases were treated with rituximab when they expe-rienced disease relapse. As a result, 2 cases (20%) achieved complete remission (CR), and 8 cases (80%) achieved partial remission (PR). The median follow-up time was 13.5 months, and 4 cases relapsed.
CONCLUSION: Pituitary and dura are common affected organs of IgG4-RD with CNS involvement. Most IgG4-RD patients with CNS involvement are combined with other organ involvement, but half of them presented nervous system involvement as the initial manifestation, and the symptoms are not typical. In order to make an early diagnosis, laboratory, imaging examination and tissue biopsy should be taken into consideration in combination if necessary.

Entities:  

Keywords:  Central nervous system; Diagnosis, differential; Hypophysitis; Immunoglobulin G4-related diseases; Meningitis

Mesh:

Substances:

Year:  2021        PMID: 34916679      PMCID: PMC8695141     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  12 in total

1.  Idiopathic hypertrophic pachymeningitis mimicking neurosarcoidosis.

Authors:  Panos G Christakis; Duarte G Machado; Pooia Fattahi
Journal:  Clin Neurol Neurosurg       Date:  2011-11-08       Impact factor: 1.876

2.  IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease.

Authors:  Siu-Ki Chan; Wah Cheuk; Kwan-Tsz Chan; John K C Chan
Journal:  Am J Surg Pathol       Date:  2009-08       Impact factor: 6.394

Review 3.  IgG4-related disease.

Authors:  Terumi Kamisawa; Yoh Zen; Shiv Pillai; John H Stone
Journal:  Lancet       Date:  2014-12-04       Impact factor: 79.321

4.  Immunoglobulin g4-related hypertrophic pachymeningitis with skull involvement.

Authors:  Young-Sub Lee; Hye Won Lee; Ki-Su Park; Seong-Hyun Park; Jeong-Hyun Hwang
Journal:  Brain Tumor Res Treat       Date:  2014-10-31

5.  Clinical outcomes and predictive relapse factors of IgG4-related disease following treatment: a long-term cohort study.

Authors:  Y Peng; J Q Li; P P Zhang; X Zhang; L Y Peng; H Chen; J X Zhou; S Z Zhang; H X Yang; J J Liu; H F Guo; J Li; X Zhang; Y Zhao; X F Zeng; F C Zhang; Y Y Fei; W Zhang
Journal:  J Intern Med       Date:  2019-06-17       Impact factor: 8.989

Review 6.  Prednisolone markedly reduced serum IgG4 levels along with the improvement of pituitary mass and anterior pituitary function in a patient with IgG4-related infundibulo-hypophysitis.

Authors:  Izumi Iseda; Kazuyuki Hida; Atsuhiko Tone; Masafumi Tenta; Yusuke Shibata; Kiyoshi Matsuo; Ichiro Yamadori; Kozo Hashimoto
Journal:  Endocr J       Date:  2013-12-10       Impact factor: 2.349

7.  [Analysis of the clinical features and misdiagnosis reasons of 17 patients misdiagnosed with IgG4-related disease].

Authors:  Z Q Wang; Y Y Liu; X Zhang; T Liu; L M Ren; D H Shen; Y Wang; Z G Li
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-12-18

8.  IgG4-related hypophysitis: a new addition to the hypophysitis spectrum.

Authors:  Paola Leporati; Melissa A Landek-Salgado; Isabella Lupi; Luca Chiovato; Patrizio Caturegli
Journal:  J Clin Endocrinol Metab       Date:  2011-05-18       Impact factor: 5.958

9.  A new clinicopathological entity of IgG4-related autoimmune disease.

Authors:  Terumi Kamisawa; Nobuaki Funata; Yukiko Hayashi; Yoshinobu Eishi; Morio Koike; Kouji Tsuruta; Atsutake Okamoto; Naoto Egawa; Hitoshi Nakajima
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

10.  Clinical features of immunoglobulin G4-related disease with central nervous system involvement: an analysis of 15 cases.

Authors:  Linyi Peng; Panpan Zhang; Xia Zhang; Jieqiong Li; Jiuliang Zhao; Jinjin Liu; Yunyun Fei; Wen Zhang; YIcheng Zhu; Yan Zhao; Xiaofeng Zeng
Journal:  Clin Exp Rheumatol       Date:  2020-02-14       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.